SURMOUNT trial programme: difference between revisions
Diff·revision 7 → 8·20:17, 24 Oct 2024
Difference between revision 7 and revision 8 of SURMOUNT trial programme. 2 lines changed; the page grew by 101 bytes.
| Revision 7 — 11:09, 5 Oct 2024 LeaderLoic (talk) rm the cross-trial comparison; the populations are not comparable 2,567 bytes ±0 | Revision 8 — 20:17, 24 Oct 2024 StyleSheetSybil (talk) expand §Scope of the evidence 2,668 bytes +101 | ||
|---|---|---|---|
| 1 | {{Infobox concept | 1 | {{Infobox concept |
| 2 | | name = SURMOUNT trial programme | 2 | | name = SURMOUNT trial programme |
| + | 3 | | image = trial-bars.svg | |
| + | 4 | | caption = Weight change by dose in the principal obesity trial. | |
| 3 | | Drug = [[Tirzepatide|Tirzepatide]] 5, 10 and 15 mg weekly | 5 | | Drug = [[Tirzepatide|Tirzepatide]] 5, 10 and 15 mg weekly |
| 4 | | Indication = Chronic weight management | 6 | | Indication = Chronic weight management |